Conduit PharmaceuticalsNASDAQ: CDT

SAN DIEGO and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) --   Conduit Pharmaceuticals Inc. (Nasdaq: CDT ) (“Conduit” or the “Company”), today announces the filing of two new patent applications relating to its lead clinical candidate, AZD1656, a HK-4 glucokinase activator licensed from AstraZeneca targeting a broad spectrum of autoimmune disorders.

SAN DIEGO and LONDON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT ) (“Conduit” or the “Company”), today announced the restructuring of a portion of its financial obligations, enhancing its balance sheet and liquidity. The Company has restructured the $2.65 million loan note with Nirland Limited (“Nirland”) and secured $1.2 million in new promissory notes through separate agreements with third parties.

Conduit Pharmaceuticals (NASDAQ: CDT ) stock is up on Wednesday following a shareholder update concerning a major investor in the company. New filings with the Securities and Exchange Commission (SEC) reveal that Nirland Limited holds a 14.8% stake in CDT stock.

Initial joint project in Fuzhou expected to generate an increase in revenue by more than 50% over next three years Initial joint project in Fuzhou expected to generate an increase in revenue by more than 50% over next three years

Three Phase Project Will Process 400,000 Tons/Day and Has Initial Contract Value of 1.16B RMB Three Phase Project Will Process 400,000 Tons/Day and Has Initial Contract Value of 1.16B RMB

SHENZHEN, China, May 20, 2024 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (“CDT”), a leading provider of waste treatment systems and services throughout China, today announces that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (the “SEC”) on May 15, 2024. The annual report on Form 20-F, which contains CDT's audited consolidated financial statements, can be accessed through the SEC's website at www.sec.gov or CDT's website at https://www.cdthb.cn.

The U.S. House of Representatives passed a bill on March 13 that stated a requirement for ByteDance, a reputable Chinese tech company, to ban TikTok in the United States. The legislation, now known as the Protecting Americans from Foreign Adversary Controlled Application Act , was forwarded by the U.S. government Reps.

Conduit Pharmaceuticals (NASDAQ: CDT ) stock is rocketing higher on Monday despite a lack of news from the biopharmaceutical company. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why CDT stock is rising today.